Organon (OGN) EV to CFO (2021 - 2026)
Organon (OGN) posted EV to CFO of 22.65 for Q2 2026, up 1014.58% on a QoQ basis from 2.03 in Q1 2026, and up 159.89% year-over-year from 8.72 in Q2 2025.
Analysis
Organon (OGN) EV to CFO (2021 - 2026) Analysis & Trends
Organon has reported EV to CFO for 6 years, with the latest figure at 22.65 in Q2 2026.
- On a quarterly basis, EV to CFO rose 159.89% year-over-year to 22.65 in Q2 2026; TTM through Jun 2026 was 3.29, a 41.67% increase from a year earlier, with the FY2025 full-year figure at 1.85, down 44.83% from the prior year.
- EV to CFO was 22.65 for Q2 2026 at Organon, up from 2.03 in the prior quarter.
- The five-year high for EV to CFO was 184.9 in Q2 2023, with the low at 2.03 in Q1 2026.
- Average EV to CFO over 5 years is 34.38, with a median of 19.93 recorded in 2026.
- The sharpest annual moves came in 2023 and 2026: EV to CFO jumped 247.34% in 2023, then tumbled 95.37% in 2026.
- Over 5 years, EV to CFO stood at 23.96 in 2022, then tumbled by 68.63% to 7.52 in 2023, then advanced by 7.19% to 8.06 in 2024, then grew by 13.76% to 9.17 in 2025, then surged by 147.12% to 22.65 in 2026.
- The last three EV to CFO figures came in at 22.65 (Q2 2026), 2.03 (Q1 2026), and 9.17 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.65 |
| Mar 31, 2026 | 2.03 |
| Dec 31, 2025 | 9.17 |
| Sep 30, 2025 | 7.97 |
| Jun 30, 2025 | 8.72 |
| Mar 31, 2025 | 43.92 |
| Dec 31, 2024 | 8.06 |
| Sep 30, 2024 | 29.53 |
| Jun 30, 2024 | 13.93 |
| Mar 31, 2024 | 55.72 |
| Dec 31, 2023 | 7.52 |
| Sep 30, 2023 | 15.42 |
| Jun 30, 2023 | 184.90 |
| Mar 31, 2023 | 48.47 |
| Dec 31, 2022 | 23.96 |
| Sep 30, 2022 | 17.20 |
| Jun 30, 2022 | 53.23 |
| Mar 31, 2022 | 66.39 |
| Dec 31, 2021 | 148.64 |
| Sep 30, 2021 | 19.85 |